BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24183115)

  • 1. [Association between venous thrombosis and dyslipidemia].
    García Raso A; Ene G; Miranda C; Vidal R; Mata R; Llamas Sillero MP
    Med Clin (Barc); 2014 Jul; 143(1):1-5. PubMed ID: 24183115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].
    González-Juanatey JR; Cordero A; Vitale GC; González-Timón B; Mazón P; Bertomeu V
    Rev Esp Cardiol; 2011 Oct; 64(10):862-8. PubMed ID: 21835533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
    Za T; De Stefano V; Rossi E; Petrucci MT; Andriani A; Annino L; Cimino G; Caravita T; Pisani F; Ciminello A; Torelli F; Villivà N; Bongarzoni V; Rago A; Betti S; Levi A; Felici S; Gentilini F; Calabrese E; Leone G;
    Br J Haematol; 2013 Mar; 160(5):673-9. PubMed ID: 23240810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
    Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
    PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein and the risk of recurrent venous thromboembolism.
    Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
    Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism--a manifestation of the metabolic syndrome.
    Ay C; Tengler T; Vormittag R; Simanek R; Dorda W; Vukovich T; Pabinger I
    Haematologica; 2007 Mar; 92(3):374-80. PubMed ID: 17339187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.
    Cabrera M; Sánchez-Chaparro MA; Valdivielso P; Quevedo-Aguado L; Catalina-Romero C; Fernández-Labandera C; Ruiz-Moraga M; González-Santos P; Calvo-Bonacho E;
    Atherosclerosis; 2014 Aug; 235(2):562-9. PubMed ID: 24956529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiovascular risk factors in Lithuanian middle-aged subjects participating in the primary prevention program, analysis of the period 2009-2012.
    Laucevičius A; Rinkūnienė E; Skujaitė A; Petrulionienė Ž; Puronaitė R; Dženkevičiūtė V; Kasiulevičius V; Jatužis D; Ryliškytė L; Šlapikas R
    Blood Press; 2015 Feb; 24(1):41-7. PubMed ID: 25268930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES study].
    Gómez-Barrado JJ; Ortiz C; Gómez-Turégano M; Gómez-Turégano P; Garcipérez-de-Vargas FJ; Sánchez-Calderón P
    Clin Investig Arterioscler; 2017; 29(1):13-19. PubMed ID: 28062171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
    Green D
    Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran.
    Fesharakinia A; Zarban A; Sharifzadeh GR
    Arch Iran Med; 2008 Nov; 11(6):598-601. PubMed ID: 18976028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.